VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,304,970 | +58.9% | 791,712 | +77.8% | 0.06% | +37.5% |
| Q2 2023 | $13,404,340 | -31.9% | 445,179 | -26.8% | 0.04% | -4.8% |
| Q1 2023 | $19,684,425 | +89.2% | 608,483 | +67.6% | 0.04% | +40.0% |
| Q4 2022 | $10,404,411 | -7.6% | 363,029 | -22.3% | 0.03% | -11.8% |
| Q3 2022 | $11,264,000 | +91.3% | 467,030 | +117.2% | 0.03% | +78.9% |
| Q2 2022 | $5,889,000 | -42.4% | 215,063 | -19.3% | 0.02% | -40.6% |
| Q1 2022 | $10,223,000 | +20.4% | 266,580 | +0.5% | 0.03% | +10.3% |
| Q4 2021 | $8,494,000 | -26.3% | 265,187 | -32.2% | 0.03% | -29.3% |
| Q3 2021 | $11,524,000 | +59.3% | 391,050 | +83.7% | 0.04% | +41.4% |
| Q2 2021 | $7,234,000 | +43.8% | 212,871 | +37.6% | 0.03% | +31.8% |
| Q1 2021 | $5,029,000 | -67.7% | 154,719 | -64.2% | 0.02% | -67.6% |
| Q4 2020 | $15,579,000 | -35.4% | 432,497 | -29.7% | 0.07% | -46.9% |
| Q3 2020 | $24,101,000 | +156.1% | 615,462 | +139.9% | 0.13% | +113.3% |
| Q2 2020 | $9,411,000 | +40.0% | 256,571 | -12.1% | 0.06% | +17.6% |
| Q1 2020 | $6,723,000 | -62.0% | 291,790 | -51.7% | 0.05% | -58.2% |
| Q4 2019 | $17,676,000 | +135.8% | 603,663 | +115.1% | 0.12% | +90.6% |
| Q3 2019 | $7,495,000 | -43.7% | 280,600 | -46.1% | 0.06% | -44.3% |
| Q2 2019 | $13,317,000 | -6.4% | 521,000 | -17.9% | 0.12% | +3.6% |
| Q1 2019 | $14,229,000 | -38.5% | 634,619 | -42.2% | 0.11% | -34.7% |
| Q4 2018 | $23,149,000 | +124.7% | 1,097,641 | +97.3% | 0.17% | +209.1% |
| Q3 2018 | $10,302,000 | +59.2% | 556,251 | +91.8% | 0.06% | +57.1% |
| Q2 2018 | $6,470,000 | -59.2% | 290,030 | -59.8% | 0.04% | -61.5% |
| Q1 2018 | $15,857,000 | +64.9% | 721,405 | +74.3% | 0.09% | +93.6% |
| Q4 2017 | $9,619,000 | -23.7% | 413,800 | -24.6% | 0.05% | -25.4% |
| Q3 2017 | $12,607,000 | +82.8% | 548,994 | +75.5% | 0.06% | +50.0% |
| Q2 2017 | $6,897,000 | +39.0% | 312,781 | +43.8% | 0.04% | +20.0% |
| Q1 2017 | $4,962,000 | +2.7% | 217,450 | -6.0% | 0.04% | +2.9% |
| Q4 2016 | $4,833,000 | -62.1% | 231,221 | -52.1% | 0.03% | -59.0% |
| Q3 2016 | $12,763,000 | +88.4% | 482,700 | +97.6% | 0.08% | +88.6% |
| Q2 2016 | $6,773,000 | – | 244,281 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |